SCHEMBL6173143

SCHEMBL6173143

Nc1nc(-c2ccc(NC(=O)CN(C(=O)c3ccc(F)cc3)c3ccc(OCC(=O)O)cc3)cc2)cs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 8/20 0.44
▸ MAPT P10636 7/20 0.44
▸ MEN1 O00255 7/20 0.44
▸ LMNA P02545 3/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ MAPK1 P28482 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ PTPN7 P35236 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ DUSP3 P51452 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6173338 0.90 RAB9A (0.50) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL27601320 0.88 MEN1 (0.48) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL27583802 0.87 KMT2A (0.48) KMT2AMAPTMEN1LMNAALDH1A1
Hydrochloric Acid SCHEMBL6174792 0.87 MEN1 (0.48) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL28752208 0.84 MAPT (0.48) KMT2AMAPTMEN1ALDH1A1RAB9A
SCHEMBL6177498 0.84 RAB9A (0.47) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL6174481 0.83 RAB9A (0.48) KMT2AMAPTMEN1ALDH1A1RAB9A
SCHEMBL6172087 0.82 KMT2A (0.47) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL27601307 0.82 RAB9A (0.46) KMT2AMAPTMEN1LMNAALDH1A1
Hydrochloric Acid SCHEMBL6174064 0.82 RAB9A (0.45) KMT2AMAPTMEN1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 — — US disclosed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 — — EP disclosed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 — — US disclosed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034232-A1 Amide derivative HDAC2, ZC3HAV1, HDAC4 KMT2A 111/4885MAPT 1746/4885MEN1 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback